Original Title: Beta-blocker use is associated with lower stroke and death after carotid artery stenting. Reference: Tammman Obeid, et al. J Vasc. Surg. 2016;63:363-9. Courtesy of Dr. Carlos Fava. The latest trials on Carotid Artery Stenting (CAS) have shown significantly improved effectiveness. The use of drugs such as beta blockers (BB) have proved beneficial in some<a href="https://solaci.org/en/2016/03/01/beta-blockers-could-improve-outcomes-in-carotid-artery-stenting/" title="Read more" >...</a>
Predictors of Carotid Occlusion Intolerance during Proximal Protected Carotid Artery Stenting
Original title: Predictors of Carotid Occlusion Intolerance During Proximal Protected Carotid Artery Stenting. Reference: Giuseppe Giugliano et al. J Am Coll Cardiol Intv 2014, Epub ahead of print. Proximal endovascular occlusion devices (PEO) have been proved particularly effective and safe for proximal protected carotid stenting procedures. However, endovascular occlusion can expose the ipsilateral hemisphere to hypoperfusion and produce<a href="https://solaci.org/en/2014/10/27/n-4789/" title="Read more" >...</a>
Proximal protection devices could be the first choice for most carotid artery stenting procedures
Original title: Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection. Reference: Hornung M et al. EuroIntervention. 2014; Epub ahead of print. This series of the Frankfurt CardioVascular Center included 124 consecutive patients undergoing carotid angioplasty with proximal protection. The first 92 patients received the Gore Flow Reversal System (WL Gore;<a href="https://solaci.org/en/2014/07/31/n-4635/" title="Read more" >...</a>
Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis
The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter. This study included all<a href="https://solaci.org/en/2017/10/04/endarterectomy-vs-stenting-in-asymptomatic-carotid-artery-stenosis/" title="Read more" >...</a>
Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes
Extracranial carotid artery disease represents 15 to 20% of all strokes. Carotid revascularization plays a role in primary and secondary prevention of cerebrovascular events. Outcomes of two common revascularization strategies, Carotid endarterectomy (CAE) and carotid artery stenting (CAS), have been studied and compared. In recent years, complications associated to CAS have dropped thanks to technical<a href="https://solaci.org/en/2024/04/24/carotid-endarterectomy-vs-carotid-angioplasty-in-symptomatic-and-asymptomatic-patients-30-day-outcomes/" title="Read more" >...</a>
TAVR: Vascular Access in Patients with Peripheral Artery Disease, 1-Year Outcomes
At present, the transfemoral access (TFA) is the preferred approach when it comes to transcatheter aortic valve replacement (TAVR). However, 5 to10% of PAD patients present tortuous iliac anatomy and calcification, aortic aneurysms or prior peripheral intervention, which makes it impossible. There are several alternatives to approach these patients: 1) TFA associated to peripheral PCI<a href="https://solaci.org/en/2023/03/17/tavr-vascular-access-in-patients-with-peripheral-artery-disease-1-year-outcomes/" title="Read more" >...</a>
Symptomatic Carotid Arteries: Early or Late Emergency Revascularization?
Carotid endarterectomy continues to be the safest technique for emergency revascularization. However, 48 hours after index event, different strategy outcomes will become comparable. Multiple advances in device development have brought promising results for carotid revascularization patients with symptomatic stenosis. Regardless these developments, optimal revascularization timing after index event remains unclear. This study included patients with<a href="https://solaci.org/en/2022/01/11/symptomatic-carotid-arteries-early-or-late-emergency-revascularization/" title="Read more" >...</a>
Contralateral Occluded Carotid Defines Revascularization Strategy
A significative lesion to the carotid artery in addition to contralateral carotid occlusion is an obvious factor of high risk for a revascularization procedure. However, this might be true for surgery but not for carotid artery stenting according to this recent publication in JACC. The presence of contralateral carotid occlusion has been established as high<a href="https://solaci.org/en/2021/03/11/contralateral-occluded-carotid-defines-revascularization-strategy/" title="Read more" >...</a>
Asymptomatic Carotid Artery Stenosis: Do We Have All the Answers?
Advancements in therapies to reduce the impact of stroke in asymptomatic carotid artery stenosis have been hard to come by over the last decade. Several points of disagreement among published randomized trials prevented their information from being integrated into daily clinical practice. However, over the past 5 years, there has been some alignment, allowing for this<a href="https://solaci.org/en/2020/05/11/asymptomatic-carotid-artery-stenosis-do-we-have-all-the-answers/" title="Read more" >...</a>
Crest-2 Registry: Carotid PCI Presents Low Rates of Death and Stroke
Courtesy of Dr. Carlos Fava. In modern studies, carotid artery stenting (CAS) has been shown equal to surgery in terms of the composite end point of periprocedural stroke, death, acute myocardial infarction and late ipsilateral stroke. This was tested in different groups and by trained operators. In the CREST-2 Registry (C2R) 2141 patients were included,<a href="https://solaci.org/en/2020/01/27/crest-2-registry-carotid-pci-presents-low-rates-of-death-and-stroke/" title="Read more" >...</a>